News And Resources

17 Sep 2020

Veredus Laboratories Launches Next Generation COVID-19 Diagnostic Test Using Samples Directly from Saliva or Swab

Veredus Laboratories Pte Ltd (“Veredus”) announced today the launch of its Extraction-free RT-PCR Suite consisting of VereRT™ COVID-19 PCR Kit (formerly known as VereRTCoV™ SARSCoV-2 Real-Time RT-PCR 2.0) for direct use either on human saliva (ZeroPrep™ Saliva Collection Kit, formerly known as VereRTCoV™ ZeroStep Saliva Collection Kit) or from swab (ZeroPrep™ Swab Buffer Kit). Saliva […]

24 Jun 2020

Veredus Laboratories Launches VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 as CE-IVD Test Kit for Diagnostic Use across Europe

Veredus Laboratories Pte Ltd “Veredus” has received CE-IVD marking for VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 as a molecular diagnostic test kit to be used in clinical practice across Europe and other countries that recognize the CE Mark. This announcement follows the recent commercial launch of this IVD test with approvals from Health Sciences Authority (HSA) […]

16 Jun 2020

The Food and Drug Administration (FDA) of the Philippines has Approved Veredus Laboratories’ VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 for Commercial Use as an IVD Test for COVID-19

Singapore, June 15, 2020 – Veredus Laboratories Pte Ltd “Veredus” announced that the VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 is now approved for commercial use as an In vitro Diagnostic (IVD) test in the Philippines by the Food and Drug Administration (FDA). This product was also authorised by the Singapore Health Sciences Authority (HSA) in early […]

05 Jun 2020

Veredus Laboratories’ VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 Receives Provisional Authorisation from the Health Sciences Authority (HSA) in Singapore for In vitro Diagnostic (IVD) Use

Veredus Laboratories Pte Ltd “Veredus” has obtained Provisional Authorisation from Singapore Health Sciences Authority (HSA) for VereRTCoV™ SARS-CoV-2 Real-Time RT-PCR 2.0 for use as an In vitro Diagnostic (IVD) test in Singapore. Veredus can supply to healthcare institutions, private hospitals, medical clinics and clinical laboratories licensed under the Private Hospitals and Medical Clinics (PHMC) Act […]

28 Apr 2020

Singapore HSA issued Veredus Laboratories with Provisional Authorisation for LIONRUN Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 for In vitro Diagnostic (IVD) use

Veredus Laboratories Pte Ltd “Veredus” announced today that it has received Provisional Authorisation from Singapore Health Sciences Authority (HSA) for LIONRUN Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19 “LIONRUN Antibody Kit”. Veredus can supply to the healthcare institutions, private hospitals, medical clinics or clinical laboratories licensed under the PHMC Act (Cap. 248) for […]

30 Mar 2020

Veredus Laboratories Announces CE-IVD Marking of VereCoV™ Detection Kit for Diagnosis of COVID-19

Veredus Laboratories Pte Ltd “Veredus” today announced the CE-IVD marking of VereCoV™ Detection Kit for commercial launch in Europe. The test is intended for the qualitative detection of 2019 novel Coronavirus (2019-nCoV) also known as SARSCoV- 2 that causes COVID-19. The kit was developed to provide an easy-to-use solution for clinical testing, public health surveillance […]

Categories

Archives